Pharma Industry Has Shown ‘Huge Interest’ In AI For Drug Development, Says EMA

 
• By Eliza Slawther
  
Generate a summary of this article
Listen to this article
Beta

The EMA received more than 1,000 responses to its draft reflection paper on AI in drug development, some of which will be incorporated into the final document, an agency representative told this week’s RAPS Euro Convergence 2024.

RAPS Euro Convergence 2024, AI panel discussion
Claire Harrison, Helena Corte-Real Correia and Khushboo Sharma at the RAPS Euro Convergence 2024 • Source: Pink Sheet

The use of AI in drug development and regulation was a hot topic among speakers and attendees at the RAPS Euro Convergence 2024 meeting, held on 6-8 May in Berlin, Germany. Industry representatives shared many examples of how the use of AI was now widespread throughout the drug R&D process, while regulators provided updates on their own efforts to keep pace with the growing use of this technology.

Florian Lasch, a biostatistics specialist at the European Medicines Agency, said during a panel discussion on 7 May that the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

EU Biosimilar Filings, Opinions And Approvals

 
• By Saba Afreen

<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

EU Pharma Reform: What You Need to Know Now

 
• By Anabel Costa-Ferreira and Ian Schofield

As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

New EU Approvals

<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description